Work

Phase I study of NPI-2358 (a novel vascular disrupting agent) in patients with solid tumors and lymphomas

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.3525

Authors: A. C. Mita, L. K. Yee, K. P. Papadopoulos, E. I. Heath, O. Romero, G. K. Lloyd, G. Cropp, M. A. Spear, M. M. Mita, P. M. LoRusso

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2265376287

Cites:

Cited by: 7

Related to: 10